If you wanted more details of MDS’ deal to sell its analytical technologies business to Danaher, today is your lucky day. The management proxy circular for the shareholders’ meeting to vote on the deal was filed on EDGAR and SEDAR. Here’s a direct link to the EDGAR filing.
Categories: Jeremy Grushcow · News
Tagged: MDS, MDS Inc., Danaher, MDS Analytical Technologies
The International Medical Corps asked me to post this link to their Haiti donations page. With 92% of their resources going to program activities, I am glad to do so. Thanks for spurring me to add these links.
To donate to UJA's Haiti Disaster Relief Fund, you can visit ujadonations.com/haiti or call 416.631.5705.
Other information on helping in Haiti can be found from the Department of Foreign Affairs and International Trade for Canadians and from the Department of State in the U.S.
The views expressed here are solely the authors’ and should not be attributed to any of their firms or clients. The material and information provided on this website are for general information only and should not be relied on as legal or business advice or as a legal opinion. The authors make no claims, promises or guarantees about the accuracy, completeness, currency, or adequacy of any information linked or referred to or contained on this blog. No person should act or refrain from acting in reliance on any information found on this blog without first obtaining appropriate professional advice from a consultant or from a lawyer duly licensed to practise law in the relevant province, state, territory or country. These materials do not create a solicitor-client relationship between you and any author. Please note that the authors will not provide free legal, financial or other advice. Please don’t send us any confidential information or questions by email or otherwise because any information sent to us cannot be considered to be privileged or confidential. Note that by accessing, commenting on or linking to the blog, you (like us) are subject to the WordPress Terms of Service. Most images are from Wikimedia Commons or from governments, others link back to commercial sources. If you want us to remove an image, just let us know.
Blog at WordPress.com. Theme: Cutline by Chris Pearson.
2 responses so far ↓
Monday Biotech Deal Review: October 12, 2009 « The Cross-Border Biotech Blog // October 12, 2009 at 11:05 pm |
[...] Inc. (TSX: MDS) (NYSE: MDZ) got a boost in its sale of its analytical technologies business, with leading proxy advisory firms (RiskMetrics Group, PROXY Governance Inc., and Glass, Lewis [...]
Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog // October 26, 2009 at 7:03 am |
[...] (TSX: MDS) (NYSE: MDZ) announced that over 99% of the Common Shares were voted in favour of the sale of its MDS Analytical Technologies business to Danaher Corporation (NYSE: DHR) for $650 million in cash. MDS is also intent on selling its [...]